APOC3 and diabetes mellitus: To better understand how APOC3 silencing might impact monocyte recruitment, monocyte surface expression of molecules known to regulate adhesion and migration was evaluated after 4 weeks of diabetes, all in the setting of LDLR ASO (Figure 5A and Supplemental Table 5).